Monoclonal Antibody Therapeutics Market Size And Share

  • Report Code : TIPRE00003417
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Monoclonal Antibody Therapeutics (mABs) Market Share and Business Opportunities 2030

Buy Now

Monoclonal Antibody Therapeutics (mABs) Market Report Monoclonal Antibody Therapeutics (mABs) Market Scope and Analysis Monoclonal Antibody Therapeutics (mABs) Market Size and Share

Monoclonal Antibody Therapeutics (mABs) Market: Strategic Insights

Monoclonal Antibody Therapeutics (mABs) Market

  • CAGR (2022 - 2030)
    13.9%
  • Market Size 2022
    US$ 192.04 Billion
  • Market Size 2030
    US$ 542.80 Billion

Market Dynamics

GROWTH DRIVERS
  • Increasing prevalence of chronic diseases
  • Demand for effective cancer therapies
FUTURE TRENDS
  • Rising demand for monoclonal antibodies
  • Increasing adoption of biosimilars
OPPORTUNITIES
  • Expansion in oncology market
  • Rise in targeted and precision therapies

Key Players

  • GlaxoSmithKline
  • F Hoffmann La Roche
  • Bayer AG
  • Amgen
  • Novartis
  • AbbVie
  • Bristol Myers Squibb
  • Janssen Pharmaceutical
  • Merck KgaA

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product
  • Recombinant mABs
  • Antibody Drug Conjugates
  • Bispecific and Multispecific mABs
  • Biosimilars
Application
  • Oncology
  • Autoimmune Disease
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies